Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Two accurate methods were developed to measure finasteride in tablets.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

Fennel extract cream can reduce hair thickness in people with excessive hair growth.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Clofazimine effectively treated ashy dermatosis in a patient.

Pegvaliase is recommended for treating adults with phenylketonuria.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Finasteride is mostly broken down in the body and excreted in urine and feces.

Nilotinib can cause keratosis pilaris, a skin condition.

A reliable method was developed to measure perospirone levels in human plasma for clinical use.

Gefitinib can cause hair loss without scarring.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Tofacitinib might be used to treat hair loss.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Rifampicin effectively treated tufted hair folliculitis with no relapse after one year.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.